NEW YORK – One Codex and Transnetyx said on Wednesday they will be jointly offering end-to-end microbiome sequencing and analysis services for human and mouse samples.
"Through this partnership, Transnetyx and One Codex can offer researchers fully automated DNA extraction, library preparation, and sequencing with faster turnaround times and a lower price than ever before," One Codex CEO Nick Greenfield said in a statement. "Sequencing results will be uploaded and analyzed automatically on One Codex for a seamless experience."
Financial and other details of the deal were not disclosed.
Based in Memphis, Tennessee, Transnetyx offers genotyping services, including detecting transgenic mutations, SNPs, and CRISPR-mediated mutations in animal research models. Thompson Street Capital acquired the company as part of a 2018 deal to buy YX Genomics Holding.
Founded in 2014, One Codex offers a bioinformatics platform for microbial genomics. It launched an end-to-end microbiome sequencing and analysis service in November 2020. In 2017, the firm partnered with ATCC on microbiome research tools.